BioHarvest Sciences Inc.

BHST Consumer Defensive Packaged Foods

BioHarvest Sciences Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.5 million, up 37.0% from fiscal 2024. In the quarter to June 2026, revenue grew 3.78%, EPS grew 29.2%, free cash flow fell 64.0% and total debt fell 73.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

1.85 0.15 +8.82%
Market cap
$38.5M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
0.33
Beneish M
−2.41
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 4 4 4

+8 more TTM periods

ROE
(142.50%) (103.29%) (83.17%) (200.22%)
ROA
(30.60%) (31.71%) (30.65%) (38.97%)
ROIC
(64.30%) (66.19%) (69.80%) (136.54%)
Return on Tangible Assets
(47.22%) (41.91%) (35.76%) (92.20%)
Average Days of Receivables
42.98 33.03 30.84 27.21
Free Cash Flow per Share
(0.47) (0.42) (0.52) (0.54)
Free Cash Flow
(10.75) (9.44) (9.58) (9.46)
Capital Expenditures
(2.24) (2.26) (2.35) (2.09)
Other line items
Cash ROIC
(27.82%) (20.66%) (18.77%) (38.22%)
Accounts Receivable Turnover
10.67 12.99 14.60 14.66
Accounts Payable Turnover
4.72 4.44 4.56 3.37
Inventory Turnover
2.94 3.17 3.42 3.50
Average Days of Payables
68.85 68.76 68.33 95.31
Days of Inventory on Hand
144.84 127.44 118.59 121.27
Tax Rate
0.01 0.01 0.01 0.00
Research and Development Expense of Revenue
16.31% 15.53% 15.39% 16.54%
Selling, General and Administrative Expense of Revenue
60.63% 60.15% 60.10% 61.44%
Share Based Compensation of Revenue
2.69% 1.94% 1.73% 1.82%
Interest Coverage
(1.31) (0.98) (1.01) (1.49)
Operating CF/Net income
0.77 0.63 0.65 0.62
Depreciation/Fixed assets
0.19 0.19 0.20 0.19
Capex/Depreciation
(1.29) (1.37) (1.45) (1.37)
Revenue per Share
1.57 1.55 1.87 1.88
Operating CF per Share
(0.38) (0.32) (0.39) (0.42)
Capex per Share
(0.10) (0.10) (0.13) (0.12)
Capex to Sales
0.06 0.06 0.07 0.06

Fold the line items

Columns are period end dates